+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
ID07901179

Evaluating the Safety and Effectiveness of ALKS 7290 Added to Antidepressants in Adults with Major Depressive Disorder

Led by Alkermes, Inc. · Updated on 2026-10-28

180

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and effectiveness of ALKS 7290 as an additional treatment to antidepressants in adults with Major Depressive Disorder MDD. This Phase 2 randomized, double-blind, placebo-controlled trial focuses on adults aged 18 to 65 who have moderate to severe symptoms of depression and have not responded adequately to antidepressant therapy. The study is sponsored by Alkermes, Inc., and aims to understand how ALKS 7290 may help improve depressive symptoms while monitoring safety. Participants are randomly assigned to receive either daily oral ALKS 7290 together with their antidepressant therapy or a daily oral placebo alongside their antidepressant therapy. The treatment period lasts up to 8 weeks, during which participants continue their current antidepressant medication. The study uses a triple-blind design to ensure unbiased evaluation of outcomes. During the trial, participants undergo regular assessments including medical evaluations, psychiatric evaluations, and cardiac monitoring to ensure safety and monitor adverse events. Researchers measure treatment-emergent adverse events up to 8 weeks, as well as changes in depression severity using the Montgomery-Asberg Depression Rating Scale and the Clinical Global Impression-Severity scale from baseline through week 6. The total participation lasts up to 8 weeks, with careful monitoring throughout to evaluate both safety and symptom changes.

CONDITIONS

Brief Title

A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder

Research Team

D

Director, Clinical Trial Manager

D

Director, Clinical Trial Manager

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here